Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs FormidableMD

Belle Health
Graded #48

Higher grade

vs+3.8999999999999915
FormidableMD
Graded #74

Lower grade

The verdict

Belle Health takes it — 76.8/100 to 72.9/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +36
91
55
Dose & formulationFormidableMD +6
72
78
Clinical oversightFormidableMD +17
71
88
Labs & monitoringFormidableMD +11
72
83
FulfillmentBelle Health +13
85
72
Contract termsFormidableMD +6
55
61
Belle Health · left barFormidableMD · right bar

The numbers

MetricBelle HealthFormidableMD
WeighScore76.8/10072.9/100
GradeCC
Scorecard rank#48#74
Semaglutide$119/mo$169/mo (1 mg dose, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$199/mo (10 mg dose, compounded)
CoverageAll 50 states1 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
FormidableMD

Graded #74 · C

Strengths

  • Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
  • Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
  • Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible

Where it loses points

  • Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
  • Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
  • The 503A compounding pharmacy partner is not named on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard